Compound Detail
CHEMBL5401693
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CC(C)(O)CC(=O)N1CCc2cc(Nc3ncc(C(F)(F)F)c(NCC(C)(C)CN)n3)ccc2C1
Basic Information
| ChEMBL ID | CHEMBL5401693 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | YVGKTIYRWXKWTQ-UHFFFAOYSA-N |
3
Targets
3
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
494.6
MW (Da)
3.68
ALogP
7
HBA
4
HBD
116.4
PSA (Ų)
0.44
QED
0
Ro5 Violations
8
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 7.55
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| MV4-11 CHEMBL613835 | IC50 | 7.55 | 7.55 | 27.9 | 1 |
| Receptor-type tyrosine-protein kinase FLT3 CHEMBL1974 | IC50 | 7.04 | 7.04 | 91.4 | 1 |
| Serine/threonine-protein kinase Chk1 CHEMBL4630 | IC50 | 5.97 | 5.97 | 1064.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| MV4-11 | IC50 | = | 27.92 | nM | 7.55 | Antiproliferative activity against human MV4-11 cells assessed as reduction in c... | 37584545 |
| Receptor-type tyrosine-protein kinase FLT3 | IC50 | = | 91.43 | nM | 7.04 | Inhibition of FLT3 D835Y mutant (unknown origin) using peptide substrate TK-S an... | 37584545 |
| Serine/threonine-protein kinase Chk1 | IC50 | = | 1064.0 | nM | 5.97 | Inhibition of CHK1 (unknown origin) using peptide substrate S1 and ATP as substr... | 37584545 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 37584545 | 10.1021/acs.jmedchem.3c00245 | Receptor-type tyrosine-protein kinase FLT3 | 1 |
| 37584545 | 10.1021/acs.jmedchem.3c00245 | Serine/threonine-protein kinase Chk1 | 1 |
| 37584545 | 10.1021/acs.jmedchem.3c00245 | MV4-11 | 1 |
Data from ChEMBL 36 via Core Engine